FDA proposes removing weight-loss drug ingredients from compounding list

The wire

1. 01FDA has proposed removing key weight-loss drug ingredients from its compounding list, according to the report.
2. 02Any delisting would directly constrain 503A and 503B pharmacies and telehealth operators still supplying compounded weight-loss preparations.
3. 03Details of the affected substances, the comment period and the effective date were not set out in the report; compounders should watch the Federal Register docket.

From the source

fda proposes removing key weight-loss drug ingredients from compounding list